Inno-PD Capsule SR is a combination pharmaceutical formulation containing Domperidone 30 mg and Pantoprazole 40 mg, designed for the management of gastrointestinal disorders characterized by acid reflux, dyspepsia, and delayed gastric emptying. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastric motility and accelerates gastric emptying, thereby alleviating symptoms such as nausea, vomiting, and bloating. Pantoprazole, a proton pump inhibitor, effectively suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, providing symptomatic relief in conditions like gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome. The sustained-release (SR) formulation ensures prolonged therapeutic plasma concentrations, enhancing patient compliance and clinical efficacy. Inno-PD Capsule SR is indicated for patients requiring combined prokinetic and acid-suppressive therapy, particularly in cases where monotherapy is insufficient. The medication should be administered as prescribed by a healthcare professional, with attention to contraindications such as known hypersensitivity to either component, underlying cardiac arrhythmias, or concurrent use of QT-prolonging drugs. Common adverse effects may include headache, dry mouth, and abdominal discomfort. Regular monitoring and adherence to dosing guidelines are recommended to optimize therapeutic outcomes and minimize potential risks.

Dosage & How to Use